Condition (MeSH)
Lymphocele
ClinicalTrials.gov lists 24 trials for Lymphocele or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
24 of the 24 trials are tagged with Lymphocele itself; the rest are tagged with a narrower condition beneath it.
When did Lymphocele trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2021 | 2 |
| 2019 | 3 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 3 |
| 2014 | 1 |
| 2013 | 3 |
| 2012 | 1 |
| 2011 | 3 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Lymphocele trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 5 |
| Phase 4 | 2 |
| Not applicable | 14 |
| Observational | 3 |
How many Lymphocele trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 16 |
| Terminated | 3 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Lymphocele trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alejandro Gonzalez-Ojeda | 1 |
| Apyx Medical | 1 |
| Maciej Stukan, MD, PhD | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Cisplatin 1 | 1 |
| TACHOSIL GROUP | 1 |
| Fibrin Glue | 1 |
| Control hemipelvis | 1 |
| Fibrin sealant hemipelvis | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Lymphocele trials report? (3)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Prolonged existing hospitalization | 2 | 1 |
| Bilateral Pulmonary Embolisms | 1 | 1 |
| Rehospitalization | 1 | 1 |
Which publications cover Lymphocele? (37)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 37 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.